Enhanced stabilization of atherosclerotic plaques in apolipoprotein E-knockout mice by combinatorial toll-like receptor-1 and -2 gene silencing

Human Gene Therapy

Volumn 20, Issue 7, 2009, Pages 739-750

  Qi, Li Hang ^a   Wang, Ying ^a   Gao, Fei ^a   Zhang, Cheng ^a   Ding, Shi Fang ^a   Ni, Mei ^a   Feng, Jin Bo ^a   Zhang, Yun ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; COLLAGEN; INTERLEUKIN 6; LENTIVIRUS VECTOR; LIPID; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY; CONTROLLED STUDY; GENE; GENE SILENCING; GENETIC TRANSFECTION; IN VITRO STUDY; KNOCKOUT MOUSE; LENTIVIRINAE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RNA INTERFERENCE; SMOOTH MUSCLE FIBER; TLR1 GENE; TLR2 GENE;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BLOTTING, WESTERN; BODY WEIGHT; CELL LINE; CYTOKINES; GENE EXPRESSION REGULATION; GENE SILENCING; HUMANS; INFLAMMATION; LENTIVIRUS; MICE; MICE, KNOCKOUT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOLL-LIKE RECEPTOR 1; TOLL-LIKE RECEPTOR 2; TRANSFECTION;

LENTIVIRUS; MUS;

EID: 68949215061     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2008.203     Document Type: Article

References (32)

1. Akira, S., Uematsu, S., and Takeuchi, O. (2006). Pathogen recognition and innate immunity. Cell 124, 783-801.
2. -/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394, 894-897.
3. Edfeldt, K., Swedenborg, J., Hansson, G.K., and Yan, Z.Q. (2002). Expression of Toll-like receptors in human atherosclerotic lesions: A possible pathway for plaque activation. Circulation 105, 1158-1161.
4. Elbashir, S.M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., and Tuschl, T. (2001). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498.
5. Hajishengallis, G., Sojar, H., Genco, R.J., and DeNardin, E. (2004). Intracellular signaling and cytokine induction upon interactions of Porphyromonas gingivalis fimbriae with pattern-recognition receptors. Immunol. Invest. 33, 157-172.
6. Kirschning, C.J., and Schumann, R.R. (2002). TLR2: Cellular sensor for microbial and endogenous molecular patterns. Curr. Top. Microbiol. Immunol. 270, 121-144.
7. Kriszbacher, I., Koppan, M., and Bodis, J. (2005). Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 353, 429-430.
8. Libby, P. (2002). Inflammation in atherosclerosis. Nature 420, 868-874.
9. Liu, X., Ukai, T., Yumoto, H., Davey, M., Goswami, S., Gibson, F.C., III, and Genco, C.A. (2008). Toll-like receptor 2 plays a critical role in the progression of atherosclerosis that is independent of dietary lipids. Atherosclerosis 196, 146-154.
10. Livak, K.J., and Schmittgen, T.D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2-DDCT method. Methods 25, 402-408.
11. Lusis, A.J. (2000). Atherosclerosis. Nature 407, 233-241.
12. Martinovic, I., Abegunewardene, N., Seul, M., Vosseler, M., Horstick, G., Buerke, M., Darius, H., and Lindemann, S. (2005). Elevated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease. Circ. J. 69, 1484-1489.
13. Michelsen, K.S., Doherty, T.M., Shah, P.K., and Arditi, M. (2004). TLR signaling: An emerging bridge from innate immunity to atherogenesis. J. Immunol. 173, 5901-5907.
14. Morr, M., Takeuchi, O., Akira, S., Simon, M.M., and Muhlradt, P.F. (2002). Differential recognition of structural details of bacterial lipopeptides by Toll-like receptors. Eur. J. Immunol. 32, 3337-3347.
15. Morris, K.V., and Rossi, J.J. (2006). Lentiviral-mediated delivery of siRNAs for antiviral therapy. Gene Ther. 13, 553-558.
16. Mullick, A.E., Tobias, P.S., and Curtiss, L.K. (2005). Modulation of atherosclerosis in mice by Toll-like receptor 2. J. Clin. Invest. 115, 3149-3156.
17. Ozinsky, A., Underhill, D.M., Fontenot, J.D., Hajjar, A.M., Smith, K.D., Wilson, C.B., Schroeder, L., and Aderem, A. (2000). The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc. Natl. Acad. Sci. U.S.A. 97, 13766-13771.
18. Robbins, M., Judge, A., Ambegia, E., Choi, C., Yaworski, E., Palmer, L., McClintock, K., and MacLachlan, I. (2008). Misinterpreting the therapeutic effects of siRNA caused by immune stimulation. Hum. Gene Ther. 19, 991-999.
19. Rossi, J.J. (2008). Expression strategies for short hairpin RNA interference triggers. Hum. Gene Ther. 19, 313-317.
20. Schoneveld, A.H., Oude Nijhuis, M.M., van Middelaar, B., Laman, J.D., de Kleijn, D.P., and Pasterkamp, G. (2005). Tolllike receptor 2 stimulation induces intimal hyperplasia and atherosclerotic lesion development. Cardiovasc. Res. 66, 162-169.
21. Shiomi, M., Ito, T., Hirouchi, Y., and Enomoto, M. (2001). Fibromuscular cap composition is important for the stability of established atherosclerotic plaques in mature WHHL rabbits treated with statins. Atherosclerosis 157, 75-84.
22. Silverman, N., and Maniatis, T. (2001). NF-κB signaling pathways in mammalian and insect innate immunity. Genes Dev. 15, 2321-2342.
23. Song, E., Lee, S.K., Wang, J., Ince, N., Ouyang, N., Min, J., Chen, J., Shankar, P., and Lieberman, J. (2003). RNA interference targeting Fas protects mice from fulminant hepatitis. Nat. Med. 9, 347-351.
24. Stary, H.C., Chandler, A.B., Dinsmore, R.E., Fuster, V., Glagov, S., Insull, W., Jr., Rosenfeld, M.E., Schwartz, C.J., Wagner, W.D., and Wissler, R.W. (1995). A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 92, 1355-1374.
25. Takeda, K., and Akira, S. (2005). Toll-like receptors in innate immunity. Int. Immunol. 17, 1-14.
26. Takeuchi, O., Sato, S., Horiuchi, T., Hoshino, K., Takeda, K., Dong, Z., Modlin, R.L., and Akira, S. (2002). Cutting edge: Role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J. Immunol. 169, 10-14.
27. van Duin, D., Mohanty, S., Thomas, V., Ginter, S., Montgomery, R.R., Fikrig, E., Allore, H.G., Medzhitov, R., and Shaw, A.C. (2007). Age-associated defect in human TLR-1/2 function. J. Immunol. 178, 970-975.
28. von der Thüsen, J.H., van Berkel, T.J., and Biessen, E.A. (2001). Induction of rapid atherogenesis by perivascular carotid collar placement in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice. Circulation 103, 1164-1170.
29. -/- mice after adenovirus-mediated transfer of p53. Circulation 105, 2064-2070.
30. Yamamoto, M., Takeda, K., and Akira, S. (2004). TIR domain-containing adaptors define the specificity of TLR signaling. Mol. Immunol. 40, 861-868.
31. Zender, L., Hutker, S., Liedtke, C., Tillmann, H.L., Zender, S., Mundt, B., Waltemathe, M., Gosling, T., Flemming, P., Malek, N.P., Trautwein, C., Manns, M.P., Kuhnel, F., and Kubicka, S. (2003). Caspase 8 small interfering RNA prevents acute liver failure in mice. Proc. Natl. Acad. Sci. U.S.A. 100, 7797-7802.
32. Zhong, L., Chen, W.Q., Ji, X.P., Zhang, M., Zhao, Y.X., Yao, G.H., Zhang, P.F., Zhang, C., and Zhang, Y. (2008). Dominant-negative mutation of monocyte chemoattractant protein-1 prevents vulnerable plaques from rupture in rabbits independent of serum lipid levels. J. Cell Mol. Med. 12, 2362-2371.